Хірургічне втручання у пацієнтів, які проходять антитромбоцитарну терапію 3 страница

114. Zeymer U, Uebis R, Vogt A, Glunz HG, Vohringer HF, Harmjanz D, Neuhaus KL Randomized comparison of percutaneous transluminal coronary angioplasty and­medical therapy in stable survivors of acute myocardial infarction with single­vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte Circulation 2003;108(11):1324–1328

115. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, Forman S,­RuzylloW, Maggioni AP, White H, Sadowski Z, Carvalho AC, Rankin JM, Renkin JP,­Steg PG, Mascette AM, Sopko G, Pfisterer ME, Leor J, Fridrich V, Mark DB,­Knatterud GL. Coronary intervention for persistent occlusion after myocardial infarction N Engl J Med 2006;355(23):2395–2407

116. Nishigaki K, Yamazaki T, Kitabatake A, Yamaguchi T, Kanmatsuse K, Kodama I,­Takekoshi N, Tomoike H, Hori M, Matsuzaki M, Takeshita A, Shimbo T,­Fujiwara H. Percutaneous coronary intervention plus medical therapy reduces­the incidence of acute coronary syndrome more effectively than initial medical­therapy only among patients with low-risk coronary artery disease a randomized,­comparative, multicenter study. JACC Cardiovasc Interv 2008;1(5):469–479

117. Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary­angioplasty vs. medical treatment for non-acute coronary heart disease:­meta-analysis of randomised controlled trials. BMJ 2000;321(7253):73–77

118. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention vs. conservative­therapy in nonacute coronary artery disease: a meta-analysis. Circulation 2005;­111(22):2906–2912

119. Schomig A, Mehilli J, deWaha A, Seyfarth M, Pache J, Kastrati A. A meta-analysis of­17 randomized trials of a percutaneous coronary intervention-based strategy in­patients with stable coronary artery disease. J Am Coll Cardiol 2008;52(11):­894–904

120. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK, Kent DM. Percutaneous­coronary interventions for non-acute coronary artery disease: a quantitative­20-year synopsis and a network meta-analysis. Lancet 2009;373(9667):911–918

121. Hannan EL, Samadashvili Z, Cozzens K, Walford G, Jacobs AK, Holmes DR Jr.,­Stamato NJ, Gold JP, Sharma S, Venditti FJ, Powell T, King SB 3rd. Comparative outcomes­for patients who do and do not undergo percutaneous coronary intervention­for stable coronary artery disease in New York. Circulation 2012;125(15):­1870–1879

121a. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, Voigt JU, Zamorano JL. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2008;9(415–437.

122. Shaw LJ,Weintraub WS, Maron DJ, Hartigan PM, Hachamovitch R, Min JK, Dada M,­Mancini GB, Hayes SW, O’Rourke RA, Spertus JA, Kostuk W, Gosselin G,­Chaitman BR, Knudtson M, Friedman J, Slomka P, Germano G, Bates ER, Teo KK,­Boden WE, Berman DS. Baseline stress myocardial perfusion imaging results and­outcomes in patients with stable ischemic heart disease randomized to optimal­medical therapy with or without percutaneous coronary intervention. Am Heart­J 2012;164(2):243–250

123. Stergiopoulos K, Brown DL. Initial coronary stent implantation with medical­therapy vs.medical therapy alone for stable coronary artery disease: meta-analysis­of randomized controlled trials. Arch Intern Med 2012;172(4):312–319

124. Stettler C,Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A, Pfisterer ME,­StoneGW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabate M, Suttorp MJ, Kelbaek H,­Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS,­Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S,­Windecker S, Juni P. Outcomes associated with drug-eluting and bare-metal­stents: a collaborative network meta-analysis. Lancet 2007;370(9591):937–948

125. Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Bhatt DL, Slater J Short- and long-term outcomes with drug-eluting and bare-metal coronary stents:­a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from­randomized trials. Circulation 2012;125(23):2873–2891

126. Dangas GD, SerruysPW, Kereiakes DJ, Hermiller J, Rizvi A, NewmanW, Sudhir K,­Smith RS Jr., Cao S, Theodoropoulos K, Cutlip DE, Lansky AJ, Stone GW Meta-analysis of everolimus-eluting vs. paclitaxel-eluting stents in coronary­artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical­Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment­of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc­Interv 2013;6(9):914–922

126a. Imbert L, Poussier S, Franken PR, Songy B, Verger A, Morel O, Wolf D, Noel A, Karcher G, Marie PY. Compared performance of high-sensitivity cameras dedicated to myocardial perfusion SPECT: a comprehensive analysis of phantom and human images. J Nucl Med 2012;53:1897–1903.

127. Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, Kim HS, Park SJ, Kastrati A, de­Waha A, Krishnan P, Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J,­Kovacic J, Kini AS, Dangas GD. Impact of the everolimus-eluting stent on stent­thrombosis: a meta-analysis of 13 randomized trials. J Am Coll Cardiol 2011;­58(15):1569–1577

128. Stefanini GG, Byrne RA, Serruys PW, de Waha A, Meier B, Massberg S, Juni P,­Schomig A, Windecker S, Kastrati A. Biodegradable polymer drug-eluting stents­reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous­coronary intervention: a pooled analysis of individual patient data from the­ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. Eur Heart J 2012;­33(10):1214–1222

129. Stefanini GG, Baber U, Windecker S, Morice MC, Sartori S, Leon MB, Stone GW,­SerruysPW, WijnsW,Weisz G, Camenzind E, Steg PG, Smits PC, Kandzari D, Von­Birgelen C, Galatius S, Jeger RV, Kimura T, Mikhail G, Itchhaporia D, Mehta L,­Ortega R, Kim HS, Valgimigli M, Kastrati A, Chieffo A, Mehran R. Safety and efficacy­of drug-eluting stents in women: a patient-level pooled analysis of randomised­trials. Lancet 2013;382(9908):1879–1888

130. Stefanini GG, Kalesan B, Serruys PW, Heg D, Buszman P, Linke A, Ischinger T,­Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D,­Sohn HY, Eerdmans P, van Es GA, Meier B, Windecker S, Juni P. Long-term clinical­outcomes of biodegradable polymer biolimus-eluting stents vs. durable polymer­sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4­year follow-up of a randomised non-inferiority trial. Lancet 2011;378(9807):­1940–1948

131. Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, D’Ascenzo F,­Kimura T, Briguori C, Sabate M, Kim HS, De Waha A, Kedhi E, Smits PC,­Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon MB, StoneGW. Stent thrombosis­with drug-eluting and bare-metal stents: evidence from a comprehensive network­meta-analysis. Lancet 2012;379(9824):1393–1402

132. Bangalore S, Toklu B, Amoroso N, Fusaro M, Kumar S, Hannan EL, FaxonDP, Feit F Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer­drug eluting stents for coronary artery disease: mixed treatment comparison­meta-analysis. BMJ 2013;347:f6625

133. Kaiser C, Galatius S, Erne P, Eberli F, Alber H, Rickli H, Pedrazzini G, Hornig B,­Bertel O, Bonetti P, De Servi S, Brunner-La Rocca HP, Ricard I, Pfisterer M Drug-eluting vs. bare-metal stents in large coronary arteries. N Engl J Med 2010;­363(24):2310–2319

134. Bittl JA, He Y, Jacobs AK, YancyCW, Normand SL. Bayesian methods affirm the use­of percutaneous coronary intervention to improve survival in patients with unprotected­left main coronary artery disease. Circulation 2013;127(22):2177–2185

135. Dzavik V, GhaliWA, Norris C, Mitchell LB, Koshal A, Saunders LD, Galbraith PD,­HuiW, Faris P, Knudtson ML. Long-term survival in 11,661 patients withmultivessel­coronary artery disease in the era of stenting: a report from the Alberta Provincial­Project forOutcome Assessment in CoronaryHeart Disease(APPROACH)Investigators Am Heart J 2001;142(1):119–126

136. Smith PK, Califf RM, Tuttle RH, Shaw LK, Lee KL, Delong ER, Lilly RE, SketchMHJr.,­Peterson ED, Jones RH. Selection of surgical or percutaneous coronary intervention­provides differential longevity benefit. Ann Thorac Surg 2006;82(4):1420–1428;­discussion 1428–1429

137. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, Higgins RS,­Carlson RE, Jones RH. Drug-eluting stents vs. coronary-artery bypass grafting in­multivessel coronary disease. N Engl J Med 2008;358(4):331–341

138. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H, Taylor HA,­Chaitman BR. Comparison of surgical and medical group survival in patients with­left main equivalent coronary artery disease. Long-term CASS experience. Circulation­1995;91(9):2335–2344

139. Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M, Ocampo S, Sopko G,­Ramires JA, Schneider D, Frye RL, Bypass Angioplasty Revascularization­Investigation 2 Diabetes Study G. The Bypass Angioplasty Revascularization Investigation­2 Diabetes randomized trial of different treatment strategies in type 2 diabetes­mellitus with stable ischemic heart disease: impact of treatment strategy on­cardiac mortality and myocardial infarction. Circulation 2009;120(25):2529–2540

140. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery­bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 1985;­312(26):1665–1671

141. Jones RH, Kesler K, Phillips HR 3rd, Mark DB, Smith PK, Nelson CL, Newman MF,­Reves JG, AndersonRW, Califf RM. Long-term survival benefits of coronary artery­bypass grafting and percutaneous transluminal angioplasty in patients with coronary­artery disease. J Thorac Cardiovasc Surg 1996;111(5):1013–1025

142. BakerDW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of­heart failure. III. The role of revascularization in the treatment of patients with moderate­or severe left ventricular systolic dysfunction. JAMA 1994;272(19):­1528–1534

143. Hachamovitch R, HayesSW, Friedman JD, Cohen I, Berman DS. Comparison of the­short-term survival benefit associated with revascularization compared with­medical therapy in patients with no prior coronary artery disease undergoing­stress myocardial perfusion single photon emission computed tomography. Circulation­2003;107(23):2900–2907

144. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N, Sopko G,­Pratt C, Deanfield J, Conti CR. Asymptomatic Cardiac Ischemia Pilot (ACIP) study­two-year follow-up: outcomes of patients randomized to initial strategies of­medical therapy vs. revascularization. Circulation 1997;95(8):2037–2043

145. Thomas S, Gokhale R, Boden WE, Devereaux PJ. A meta-analysis of randomized­controlled trials comparing percutaneous coronary intervention with medical­therapy in stable angina pectoris. Can J Cardiol 2013;29(4):472–482

146. Coronary angioplasty vs. coronary artery bypass surgery: the Randomized Intervention­Treatment of Angina (RITA) trial. Lancet 1993;341(8845):573–580

147. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomized­study of coronary angioplasty compared with bypass surgery in patients­with symptomatic multivessel coronary disease. German Angioplasty Bypass­Surgery Investigation (GABI). N Engl J Med 1994;331(16):1037–1043

148. King SB 3rd, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH,­AlazrakiNP, Guyton RA, ZhaoXQ.A randomized trial comparing coronary angioplasty­with coronary bypass surgery. Emory Angioplasty vs. Surgery Trial (EAST).N­Engl J Med 1994;331(16):1044–1050

149. First-year results of CABRI (Coronary Angioplasty vs. Bypass Revascularisation Investigation) CABRI Trial Participants. Lancet 1995;346(8984):1179–1184

150. Comparison of coronary bypass surgery with angioplasty in patients with multivessel­disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators N Engl J Med 1996;335(4):217–225

150a. Halliburton S, Arbab-Zadeh A, Dey D, Einstein AJ, Gentry R, George RT, Gerber T, Mahesh M,Weigold WG. State-of-the-art in CT hardware and scan modes for cardiovascular CT. J Cardiovasc Comput Tomogr 2012;6:154–163.

151. Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S, Esposito R,­Ramanathan K, Weiman D, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S,­Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D,­Barbiere C, Lewis D, Angina With Extremely Serious Operative Mortality E. Percutaneous­coronary intervention vs. coronary artery bypass graft surgery for patients­with medically refractory myocardial ischemia and risk factors for adverse outcomes­with bypass: a multicenter, randomized trial. Investigators of the Department­of Veterans Affairs Cooperative Study #385, the Angina With Extremely­Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol 2001;­38(1):143–149

151a. Hausleiter J, Martinoff S, Hadamitzky M, Martuscelli E, Pschierer I, Feuchtner GM, Catalan-Sanz P, Czermak B, Meyer TS, Hein F, Bischoff B, Kuse M, Schomig A, Achenbach S. Image quality and radiation exposure with a low tube voltage protocol for coronary CT angiography results of the PROTECTION II Trial. JACC Cardiovasc Imaging 2010;3:1113–1123.

152. Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J, Vogel D, Grinfeld R,­Delacasa A, Garrido M, Oliveri R, Mele E, Palacios I, O’NeillW. Argentine Randomized­Study: Coronary Angioplasty with Stenting vs. Coronary Bypass Surgery in­patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up­results. ERACI II Investigators. J Am Coll Cardiol 2001;37(1):51–58

153. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, Buller N,­Bonser R, van den Brand MJ, van Herwerden LA, MorelMA, van Hout BA. Comparison­of coronary-artery bypass surgery and stenting for the treatment of multivessel­disease. N Engl J Med 2001;344(15):1117–1124

154. Coronary artery bypass surgery vs. percutaneous coronary intervention with stent­implantation in patients with multivessel coronary artery disease (the Stent or­Surgery trial): a randomised controlled trial. Lancet 2002;360(9338):965–970

155. Eefting F, Nathoe H, van Dijk D, Jansen E, Lahpor J, Stella P, SuykerW, Diephuis J,­Suryapranata H, Ernst S, Borst C, Buskens E, Grobbee D, de Jaegere P. Randomized­comparison between stenting and off-pump bypass surgery in patients referred for­angioplasty. Circulation 2003;108(23):2870–2876

155a. Brodoefel H, Burgstahler C, Tsiflikas I, Reimann A, Schroeder S, Claussen CD, Heuschmid M, Kopp AF. Dual-source CT: effect of heart rate, heart rate variability, and calcification on image quality and diagnostic accuracy. Radiology 2008;247: 346–355.

156. Thiele H, Oettel S, Jacobs S, Hambrecht R, Sick P, Gummert JF, Mohr FW,­Schuler G, Falk V. Comparison of bare-metal stenting with minimally invasive­bypass surgery for stenosis of the left anterior descending coronary artery: a­5-year follow-up. Circulation 2005;112(22):3445–3450

156a. Chen CC, Chen CC, Hsieh IC, Liu YC, LiuCY, ChanT,Wen MS,Wan YL. The effect of calcium score on the diagnostic accuracy of coronary computed tomography angiography. Int J Cardiovasc Imaging 2011;27 Suppl 1:37–42.

157. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ,­Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K,­Dawkins KD, Mohr FW. Percutaneous coronary intervention vs. coronary-artery­bypass grafting for severe coronary artery disease. N Engl J Med 2009;360(10):­961–972

158. Boudriot E, Thiele H,Walther T, Liebetrau C, Boeckstegers P, Pohl T, Reichart B,­Mudra H, Beier F, Gansera B, Neumann FJ, Gick M, Zietak T, Desch S, Schuler G,­Mohr FW. Randomized comparison of percutaneous coronary intervention with­sirolimus-eluting stents vs. coronary artery bypass grafting in unprotected left­main stem stenosis. J Am Coll Cardiol 2011;57(5):538–545

159. Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, Lee JY, Kim WJ, Kang SJ,­Lee SW, Lee CW, Park SW, Chung CH, Lee JW, Lim DS, Rha SW, Lee SG,­Gwon HC, Kim HS, Chae IH, Jang Y, Jeong MH, Tahk SJ, Seung KB. Randomized­trial of stents vs. bypass surgery for left main coronary artery disease. N Engl J­Med 2011;364(18):1718–1727

160. Kapoor JR, Gienger AL, Ardehali R, Varghese R, Perez MV, Sundaram V,­McDonald KM, Owens DK, Hlatky MA, Bravata DM. Isolated disease of the proximal­left anterior descending artery comparing the effectiveness of percutaneous­coronary interventions and coronary artery bypass surgery. JACC Cardiovasc­Interv 2008;1(5):483–491

161. Aziz O, Rao C, Panesar SS, Jones C, Morris S, Darzi A, Athanasiou T. Meta-analysis­of minimally invasive internal thoracic artery bypass vs. percutaneous revascularisation­for isolated lesions of the left anterior descending artery. BMJ 2007;334(7594):­617

162. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW,­Golding LA, Gill CC, Taylor PC, Sheldon WC et al. Influence of the­internal-mammary-artery graft on 10-year survival and other cardiac events. N­Engl J Med 1986;314(1):1–6

163. Cameron A, Davis KB, Green GE, Myers WO, Pettinger M. Clinical implications of­internal mammary artery bypass grafts: the Coronary Artery Surgery Study experience Circulation 1988;77(4):815–819

164. Lytle BW, Blackstone EH, Sabik JF, Houghtaling P, Loop FD, Cosgrove DM. The­effect of bilateral internal thoracic artery grafting on survival during 20 postoperative­years. Ann Thorac Surg 2004;78(6):2005–2012; discussion 2012–2014

165. Kurlansky PA, Traad EA, Dorman MJ, Galbut DL, Zucker M, Ebra G. Thirty-year­follow-up defines survival benefit for second internal mammary artery in­propensity-matched groups. Ann Thorac Surg 2010;90(1):101–108

166. Taggart DP, Kaul S, Boden WE, Ferguson TB Jr., Guyton RA, Mack MJ, Sergeant PT,­Shemin RJ, Smith PK, Yusuf S. Revascularization for unprotected left main stem coronary­artery stenosis stenting or surgery. J Am Coll Cardiol 2008;51(9):885–892

167. Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M,­Massberg S, Laugwitz KL, Dirschinger J, Schomig A. Paclitaxel- vs. sirolimus-eluting­stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2009;­53(19):1760–1768

168. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A,­Mack MJ, Holmes DR, Torracca L, van Es GA, Leadley K, Dawkins KD, Mohr F. Outcomes­in patients with de novo left main disease treated with either percutaneous­coronary intervention using paclitaxel-eluting stents or coronary artery bypass­graft treatment in the Synergy Between Percutaneous Coronary Intervention­with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010;121(24):­2645–2653

169. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A,­Mack MJ, Holmes DR, Choi JW, Ruzyllo W, Religa G, Huang J, Roy K,­Dawkins KD, Mohr F. Five-Year Outcomes in Patients with Left Main Disease­Treated with Either Percutaneous Coronary Intervention or Coronary Artery­Bypass Grafting in the SYNTAX Trial. Circulation 2014;129:2388–2394

170. Capodanno D, StoneGW, Morice MC, Bass TA, Tamburino C. Percutaneous coronary­intervention vs. coronary artery bypass graft surgery in left main coronary­artery disease: a meta-analysis of randomized clinical data. J Am Coll Cardiol 2011;­58(14):1426–1432

170a. Kato S, Kitagawa K, Ishida N, Ishida M, Nagata M, Ichikawa Y, Katahira K, Matsumoto Y, Seo K, Ochiai R, Kobayashi Y, Sakuma H. Assessment of coronary artery disease using magnetic resonance coronary angiography: a national multicenter trial. J Am Coll Cardiol 2010;56:983–991.

171. Buszman PE, Buszman PP, Kiesz RS, Bochenek A, Trela B, Konkolewska M,­Wallace-Bradley D, Wilczynski M, Banasiewicz-Szkrobka I, Peszek-Przybyla E,­Krol M, Kondys M, Milewski K, Wiernek S, Debinski M, Zurakowski A, Martin JL,­Tendera M. Early and long-term results of unprotected left main coronary artery­stenting: the LE MANS (Left Main Coronary Artery Stenting) registry. J Am Coll­Cardiol 2009;54(16):1500–1511

172. Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Kim JJ,­Choo SJ, Chung CH, Lee JW, ParkSW, Park SJ. Long-term outcomes after stenting­vs. coronary artery bypass grafting for unprotected left main coronary artery­disease: 10-year results of bare-metal stents and 5-year results of drug-eluting­stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization)­Registry. J Am Coll Cardiol 2010;56(17):1366–1375

172a. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501–2555.

173. Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C. Coronary Artery Bypass Grafting­vs.Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in­Multivessel Disease: Meta-analysis of Randomized Clinical Trials of the Arterial­Grafting and Stenting Era. JAMA Intern Med 2014;174(2):223–230

174. Bravata DM, Gienger AL, McDonald KM, Sundaram V, Perez MV, Varghese R,­Kapoor JR, Ardehali R, OwensDK, Hlatky MA. Systematic review: the comparative­effectiveness of percutaneous coronary interventions and coronary artery bypass­graft surgery. Ann Intern Med 2007;147(10):703–716

175. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M,­Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA,­Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J,­Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd,­Bertrand M, Fuster V, Investigators FT. Strategies for multivessel revascularization­in patients with diabetes. N Engl J Med 2012;367(25):2375–2384

176. Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ,­Morice MC, Holmes DR, Feldman TE, Staehle E, Underwood P, Dawkins KD,­Kappetein AP, Mohr FW. Coronary artery bypass grafting vs. percutaneous­coronary intervention for patients with three-vessel disease: final five-year followup­of the SYNTAX trial. Eur Heart J. Published online 21 May 2014; doi: 10.1093/­eurheartj/ehu213

177. Wu C, Camacho FT, Zhao S, Wechsler AS, Culliford AT, Lahey SJ, King SB 3rd,­Walford G, Gold JP, Smith CR, Jordan D, Higgins RS, Hannan EL. Long-term mortality­of coronary artery bypass graft surgery and stenting with drug-eluting stents Ann Thorac Surg 2013;95(4):1297–1305

178. Blazek S, Holzhey D, Jungert C, Borger MA, Fuernau G, Desch S, Eitel I, deWaha S,­Lurz P, Schuler G, Mohr FW, Thiele H. Comparison of bare-metal stenting with­minimally invasive bypass surgery for stenosis of the left anterior descending coronary­artery: 10-year follow-up of a randomized trial. JACC Cardiovasc Interv 2013;­6(1):20–26

179. Thiele H, Neumann-Schniedewind P, Jacobs S, Boudriot E,Walther T, Mohr FW,­Schuler G, Falk V. Randomized comparison of minimally invasive direct coronary­artery bypass surgery vs. sirolimus-eluting stenting in isolated proximal left anterior­descending coronary artery stenosis. J Am Coll Cardiol 2009;53(25):2324–2331

180. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D,­Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF,­WijnsW, Zahger D, Guidelines ESCCfP. ESC Guidelines for the management of­acute coronary syndromes in patients presenting without persistent ST-segment­elevation: The Task Force for the management of acute coronary syndromes­(ACS) in patients presenting without persistent ST-segment elevation of the European­Society of Cardiology (ESC). Eur Heart J 2011;32(23):2999–3054

181. Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, Widimsky P,­McCullough PA, Hunt D, Braunwald E, Yusuf S. Routine vs. selective invasive strategies­in patients with acute coronary syndromes: a collaborative meta-analysis of­randomized trials. JAMA 2005;293(23):2908–2917

182. Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasive­therapy in acute coronary syndromes: a meta-analysis of contemporary randomized­clinical trials. J Am Coll Cardiol 2006;48(7):1319–1325

183. O’Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ,­Fox KA, Lagerqvist B, McCullough PA, Murphy SA, Spacek R, Swahn E,Wallentin L,­Windhausen F, Sabatine MS. Early invasive vs.conservative treatment strategies in­women and men with unstable angina and non-ST-segment elevation myocardial­infarction: a meta-analysis. JAMA 2008;300(1):71–80

184. Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JG, Lagerqvist B,­Wallentin L. Long-term outcome of a routine vs. selective invasive strategy in­patients with non-ST-segment elevation acute coronary syndrome a meta-analysis­of individual patient data. J Am Coll Cardiol 2010;55(22):2435–2445

185. Katritsis DG, Siontis GC, Kastrati A, van’t Hof AW, Neumann FJ, Siontis KC,­Ioannidis JP. Optimal timing of coronary angiography and potential intervention­in non-ST-elevation acute coronary syndromes. Eur Heart J 2011;32(1):32–40

186. Navarese EP, Gurbel PA, Andreotti F, Tantry U, Jeong YH, Kozinski M, Engstrom T,­Di Pasquale G, Kochman W, Ardissino D, Kedhi E, Stone GW, Kubica J. Optimal­timing of coronary invasive strategy in non-ST-segment elevation acute coronary­syndromes: a systematic review and meta-analysis. Ann Intern Med 2013;158(4):­261–270

187. Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R,­Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J,­Natarajan MK, Horsman C, Fox KA, Yusuf S, Investigators T. Early vs. delayed invasive­intervention in acute coronary syndromes. N Engl J Med 2009;360(21):­2165–2175

188. Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C,­Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, StoneGW. Impact of multivessel­disease on reperfusion success and clinical outcomes in patients undergoing­primary percutaneous coronary intervention for acute myocardial infarction. Eur­Heart J 2007;28(14):1709–1716

189. Ben-Gal Y, Moses JW, Mehran R, Lansky AJ, Weisz G, Nikolsky E, Argenziano M,­Williams MR, Colombo A, Aylward PE, StoneGW. Surgical vs. percutaneous revascularization­for multivessel disease in patients with acute coronary syndromes: analysis­from the ACUITY (Acute Catheterization and Urgent Intervention Triage­Strategy) trial. JACC Cardiovasc Interv 2010;3(10):1059–1067

190. Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Dangas G,­Lazar D, Sanchez R, Fahy M, Xu K, Stone GW. Prognostic value of the SYNTAX­score in patients with acute coronary syndromes undergoing percutaneous coronary­intervention: analysis from the ACUITY (Acute Catheterization and Urgent­Intervention Triage StrategY) trial. J Am Coll Cardiol 2011;57(24):2389–2397

191. Brener SJ, Milford-Beland S, Roe MT, Bhatt DL, Weintraub WS, Brindis RG Culprit-only or multivessel revascularization in patients with acute coronary syndromes:­an American College of Cardiology National Cardiovascular Database­Registry report. Am Heart J 2008;155(1):140–146

192. Hannan EL, Samadashvili Z, Walford G, Jacobs AK, Stamato NJ, Venditti FJ,­Holmes DR Jr., Sharma S, King SB 3rd. Staged vs. one-time complete revascularization­with percutaneous coronary intervention for multivessel coronary artery­disease patients without ST-elevation myocardial infarction. Circ Cardiovasc Interv­2013;6(1):12–20

193. Rosner GF, Kirtane AJ, Genereux P, Lansky AJ, Cristea E, Gersh BJ, Weisz G,­Parise H, Fahy M, Mehran R, Stone GW. Impact of the presence and extent of incomplete­angiographic revascularization after percutaneous coronary intervention­in acute coronary syndromes: the Acute Catheterization and Urgent Intervention­Triage Strategy (ACUITY) trial. Circulation 2012;125(21):2613–2620

194. Monteiro P. Impact of early coronary artery bypass graft in an unselected acute coronary­syndrome patient population. Circulation 2006;114(1 Suppl):I467–I472

195. Parikh SV, de Lemos JA, Jessen ME, Brilakis ES, Ohman EM, Chen AY, Wang TY,­Peterson ED, Roe MT, Holper EM. Timing of in-hospital coronary artery bypass­graft surgery for non-ST-segment elevation myocardial infarction patients results­from the National Cardiovascular Data Registry ACTION Registry-GWTG­(Acute Coronary Treatment and Intervention Outcomes Network Registry-Get­With The Guidelines). JACC Cardiovasc Interv 2010;3(4):419–427

196. Greenhalgh J, Hockenhull J, Rao N, Dundar Y, Dickson RC, Bagust A. Drug-eluting­stents vs. bare metal stents for angina or acute coronary syndromes. Cochrane Database­Syst Rev 2010(5):CD004587

197. Amsterdam EA, Kirk JD, Diercks DB, Lewis WR, Turnipseed SD. Immediate exercise­testing to evaluate low-risk patients presenting to the emergency department­with chest pain. J Am Coll Cardiol 2002;40(2):251–256

198. Nyman I,Wallentin L, Areskog M, Areskog NH, Swahn E. Risk stratification by early­exercise testing after an episode of unstable coronary artery disease. The RISC­Study Group. Int J Cardiol 1993;39(2):131–142

Не нашли, что искали? Воспользуйтесь поиском: